3rd Non-Viral RNA Delivery Systems Summit

There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.

URL: Brochure: https://go.evvnt.com/2422307-3?pid=4832
Speakers: Andrew Geall, Co-Founder and Chief Development Officer, Replicate Bioscience, Anna Perdrix, Founder and Co-Chief Executive Officer, Sixfold Bioscience, and more